+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

An enormously active and selective azapeptide inhibitor of cathepsin B



An enormously active and selective azapeptide inhibitor of cathepsin B



Journal of Peptide Science 13(8): 536-543



The peptidomimetic Z-Arg-Leu-Arg-Agly-Ile-Val-OMe (where Agly means alpha-aza-glycyl, -NHNHCO-) is the strongest (K(i) = 480 pM) and the most selective inhibitor of cathepsin B to date, being approximately 2310 times as active to cathepsin B as to cathepsin K. In this paper we introduce the peptide and seek to rationalize its structure-activity relationships using molecular dynamics (MD) and NMR. It is shown that the -Agly-moiety restrains the peptide backbone to a bent shape, contrary to its parent peptide (with Gly in position 4), having its backbone extended and flexible. This fold is maintained in the plug covalently bound to the cathepsin B Cys29, in compliance with similar bends already observed in two other azapeptides attached to the active sites of cathepsin B. The MD simulation of the Z-Arg-Leu-Arg-Agly approximately cathepsin B complex suggests that, contrary to other potent inhibitors of cathepsin B, the current double Arg(1)/Arg(3) inhibitor, while maintaining the fold is able to form a unique ion cluster involving both Arg residues on the inhibitor part and two acidic Glu171 and Glu245 on the cathepsin B part, thus enhancing the affinity and subsequently the inhibiting power and selectivity of Z-Arg-Leu-Arg-Agly-Ile-Val-OMe to the observed extreme extent.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 015017981

Download citation: RISBibTeXText

PMID: 17617796

DOI: 10.1002/psc.883


Related references

Differential cathepsin responses to inhibitor-induced feedback: E-64 and cystatin C elevate active cathepsin S and suppress active cathepsin L in breast cancer cells. International Journal of Biochemistry and Cell Biology 79: 199-208, 2016

Plasminogen hydrolysis by cathepsin S and identification of derived peptides as selective substrate for cathepsin V and cathepsin L inhibitor. Biological Chemistry 391(5): 561-570, 2010

Therapeutic dosing of an orally active, selective cathepsin S inhibitor suppresses disease in models of autoimmunity. Journal of Autoimmunity 36(3-4): 201-209, 2011

A selective reversible azapeptide inhibitor of human neutrophil proteinase 3 derived from a high affinity FRET substrate. Biochemical Pharmacology 83(6): 788-796, 2012

Development of a highly potent, selective, and cell-active inhibitor of cysteine cathepsin L-A hybrid design approach. Chemical Communications 50(74): 10875-8, 2014

Structure-activity relationships of GHRP-6 azapeptide ligands of the CD36 scavenger receptor by solid-phase submonomer azapeptide synthesis. Journal of the American Chemical Society 133(32): 12493-12506, 2011

Crystal structures of recombinant rat cathepsin B and a cathepsin B-inhibitor complex. Implications for structure-based inhibitor design. Journal of Biological Chemistry 270(10): 5527-5533, 1995

Synthesis of a renin inhibitor of the azapeptide type. Liebigs Annalen der Chemie (11): 1085-1088, 1989

Novel epoxysuccinyl peptides. A selective inhibitor of cathepsin B, in vivo. Febs Letters 280(2): 311-315, 1991

MK-0822 is a potent and selective cathepsin K inhibitor that maintains. 2007

Identification of a potent and selective non-basic cathepsin K inhibitor. Bioorganic & Medicinal Chemistry Letters 16(7): 1985-1989, 2006

Identification of a potent and selective noncovalent cathepsin S inhibitor. Journal of Pharmacology and Experimental Therapeutics 308(1): 268-276, 2004

The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K. Bioorganic and Medicinal Chemistry Letters 18(3): 923-928, 2008

Antimicrobial Peptide LL-37 Is Both a Substrate of Cathepsins S and K and a Selective Inhibitor of Cathepsin L. Biochemistry 54(17): 2785-2798, 2015

Crystallization and preliminary X-ray study of the cathepsin B complexed with CA074, a selective inhibitor. Journal Of Molecular Biology. 227(3): 942-944, 1992